ALCOR Scientific, a provider of in vitro diagnostic analyzers and medical devices for enteral nutrition delivery, announced it has expanded availability of its iSED® system for erythrocyte sedimentation rate (ESR) testing to new markets to meet growing demand for this advanced technology. Initially launched in the US in late 2012, the iSED is CE marked and now available through distributors in Europe, Asia, Africa, South America and North America.
The iSED provides fully automated ESR testing - one of the most widely used lab tests worldwide, yet historically one of the most time-consuming and cumbersome to perform. The iSED transforms ESR testing by employing patented technology that delivers accurate results in 20 seconds using a blood sample of just 100uL, which is ideal when working with pediatric and geriatric patients. The iSED has a throughput of up to 180 samples per hour, made possible by its random access, continuous feed operation.
The only fully automated ESR analyzer designed and manufactured in the US, the iSED tests samples directly from standard EDTA tubes, reducing both testing costs and contaminated waste. With its closed tube sampling and no disposables required, the iSED greatly speeds processes and improves efficiency and safety for lab clinicians. The iSED's high degree of accuracy is enabled by the use of quantitative photometry to measure, in a perfectly controlled environment, the formation of the red cell aggregates (Rouleaux) in the most critical phase of the red cell sedimentation. This technology ensures the results obtained reflect the patient's inflammation status so accurately, unaffected by variables such as mixing and temperature.
"The iSED's rapid adoption is a testament to its ability to facilitate patient testing through a cost-effective and user-friendly solution that streamlines lab processes," said Carlo Ruggeri, CEO and founder. "Alcor looks forward to introducing new, innovative diagnostic and medical device products driven by the same principles."
The iSED will be featured at the ALCOR exhibit booth at the American Association of Clinical Chemistry (AACC) Annual Meeting and Expo in Chicago, Illinois, July 29-31.
Vitamin D receptor activation slows cell overgrowth in pulmonary hypertension